- absolute monocytes



Monocyte

 
This Day in History

Today's Birthday

Quotation of the Day

A monocyte is a leukocyte, part of the human body's immune system that protect against blood-borne pathogens and move quickly to sites of infection in the tissues. It is one of the five major types of white blood cell, based on the appearance of white blood cells in stained smears as viewed under a light microscope.

Microscopic anatomy

Monocytes are 12 to 20 μm in diameter. On a Wright's stained peripheral blood smear they appear larger than red blood cells and have a bluish-grey cytoplasm with a large cytoplasm to nucleus ratio. Monocytes are typically identified by flow cytometry by surface expression of the protein CD14, a receptor for bacterial endotoxin that gives rise to septicaemia.

Physiology

Monocytes are produced by the bone marrow from haematopoietic stem cell precursors, circulate in the blood stream for about one to three days and then typically move into tissues throughout the body. In the tissues monocytes mature into different types of macrophages at different anatomical locations.

Monocytes are responsible for phagocytosis (ingestion) of foreign substances in the body. Monocytes can perform phagocytosis using intermediary (opsonising) protiens such as antibodies or complement that coat the pathogen, as well as by binding to the microbe directly via pathogen-recognition receptors. Monocytes are also capable of killing infected host cells via antibody, termed antibody-mediated cellular cytotoxicity. Vacuolization may be present in a cell that has recently phagocytized foreign matter.

Monocytes which migrate from the blood stream to other tissues are called macrophages. Macrophages are responsible for protecting tissues from foreign substances but are also the predominant cells involved in atherosclerosis.

Diagnostic use

A monocyte count is part of a complete blood count and is expressed either as a ratio of monocytes to the total number of white blood cells counted, or by absolute numbers. Both may be useful. Monocytosis is the state of excess monocytes in the peripheral blood. It may be indicative of various disease states.


Blood - Blood plasma
Pluripotential hemopoietic stem cell - Red blood cells (Reticulocyte, Normoblast) - White blood cells
Lymphocytes (Lymphoblast)
T cells (Cytotoxic - Helper - Regulatory T cell) - B cells (Plasma cells & Memory B cells) - Natural killer cell
Myelocytes (Myeloblast)
Granulocytes (Neutrophil, Eosinophil, Basophil) - Mast cell precursors - Monocytes (Histiocyte, Macrophages, Dendritic cells, Langerhans cells, Microglia, Kupffer cells) - Megakaryoblast - Megakaryocyte - Platelets


Immune system
Humoral immune system - Cellular immune system - Lymphatic system - White blood cells - Antibodies - Antigen (MHC)
de:Monozyt
Search Term: "Monocyte"

Monocyte news and Monocyte articles

Here's our top rated Monocyte links for the day:

Opexa Therapeutics Launches Tovaxin(TM) Clinical Trial Website for Multiple Sclerosis 

RedNova - Feb 14 12:16 PM
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced that it has launched an information website for its Phase IIb study of Tovaxin ("TERMS" study) located at www.tovaxin.com.
Save

Opexa Announces Encouraging Clinical Data on Novel T-Cell Vaccination Therapy for Rheumatoid Arthritis 
[Press Release] Business Wire via Yahoo! Finance - Feb 06 4:30 AM
THE WOODLANDS, Texas----Opexa Therapeutics, Inc. , a company involved in the development and commercialization of cell therapies, announced encouraging data from a clinical trial of 15 patients with rheumatoid arthritis .
Save

CONVENTIONAL AND PROTEOMIC TECHNOLOGIES FOR THE DETECTION OF EARLY STAGE MALIGNANCIES: Markers for Ovarian Cancer 
RedNova - Jan 31 5:16 AM
By Lee, Catherine J; Ariztia, Edgardo V; Fishman, David A Our understanding of the tumor microenvironment continues to evolve and allows for the identification of biomarkers that should detect the presence of early stage malignancies.
Save

Opexa Achieves Midpoint in Patient Admissions in Phase IIb Trial of Tovaxin(TM) for Multiple Sclerosis 
RedNova - Jan 30 8:17 AM
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company involved in the development and commercialization of cell therapies, announced today that it has admitted the first 75 patients in its 150-patient Phase IIb clinical trial of Tovaxin in multiple sclerosis.
Save

Last Update: 2007-02-15 02:17:06

Thank you for reading the Monocyte page - absolute monocytes 

As an extra bonus here are the top searched terms over the past month for Monocyte. Now you can see what everyone else is searching for in regards to Monocyte.



absolute monocytes